| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of sperm capacitation | 1.35e-06 | 7 | 71 | 3 | GO:1902490 | |
| MousePheno | enlarged utricle | 1.87e-05 | 2 | 61 | 2 | MP:0004335 | |
| Domain | Distal-less_N | 3.79e-05 | 3 | 67 | 2 | IPR022135 | |
| Domain | DLL_N | 3.79e-05 | 3 | 67 | 2 | PF12413 | |
| Domain | Tcp11 | 7.57e-05 | 4 | 67 | 2 | IPR008862 | |
| Domain | Tcp11 | 7.57e-05 | 4 | 67 | 2 | PF05794 | |
| Domain | SAM | 4.08e-04 | 97 | 67 | 4 | IPR001660 | |
| Domain | SAM_2 | 4.91e-04 | 43 | 67 | 3 | PF07647 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ZCCHC14 ARHGAP32 FAM117A HIVEP2 DLC1 PPFIBP1 ARHGEF5 AKAP11 ITPRID2 DZIP1 MAP3K21 FAM53C PALLD | 3.69e-08 | 861 | 75 | 13 | 36931259 |
| Pubmed | Identification of a link between Wnt/β-catenin signalling and the cell fusion pathway. | 8.02e-07 | 9 | 75 | 3 | 22109522 | |
| Pubmed | Cloning and expression of a lymphocyte activation gene (LAG-1). | 4.59e-06 | 2 | 75 | 2 | 2247088 | |
| Pubmed | Ephrin-B2 governs morphogenesis of endolymphatic sac and duct epithelia in the mouse inner ear. | 1.25e-05 | 21 | 75 | 3 | 24583262 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 29987448 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 1894635 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 33968046 | ||
| Pubmed | High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. | 1.37e-05 | 3 | 75 | 2 | 8134838 | |
| Pubmed | Critical role of CCL4 in eosinophil recruitment into the airway. | 1.37e-05 | 3 | 75 | 2 | 30854716 | |
| Pubmed | Multiple products derived from two CCL4 loci: high incidence of a new polymorphism in HIV+ patients. | 1.37e-05 | 3 | 75 | 2 | 15843566 | |
| Pubmed | Identification, cloning, and characterization of an immune activation gene. | 1.37e-05 | 3 | 75 | 2 | 2462251 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 7835696 | ||
| Pubmed | The human MIP-1beta chemokine is encoded by two paralogous genes, ACT-2 and LAG-1. | 1.37e-05 | 3 | 75 | 2 | 11685466 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 34999112 | ||
| Pubmed | CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses. | 1.37e-05 | 3 | 75 | 2 | 17327452 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 2568930 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 28674422 | ||
| Pubmed | Independent expression of the two paralogous CCL4 genes in monocytes and B lymphocytes. | 1.37e-05 | 3 | 75 | 2 | 14673550 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 21912378 | ||
| Pubmed | 2.19e-05 | 709 | 75 | 9 | 22988430 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 15456894 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 17060321 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 15967376 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 12070155 | ||
| Pubmed | Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. | 2.75e-05 | 4 | 75 | 2 | 23007134 | |
| Pubmed | A novel polypeptide secreted by activated human T lymphocytes. | 2.75e-05 | 4 | 75 | 2 | 2809212 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 15897346 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 22528550 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 27177471 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 36863097 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 3058856 | ||
| Pubmed | Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. | 2.75e-05 | 4 | 75 | 2 | 16982098 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 29739756 | ||
| Pubmed | USP11 degrades KLF4 via its deubiquitinase activity in liver diseases. | 2.75e-05 | 4 | 75 | 2 | 34114341 | |
| Pubmed | A novel role of Yin-Yang-1 in pulmonary tuberculosis through the regulation of the chemokine CCL4. | 2.75e-05 | 4 | 75 | 2 | 26786659 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 16637021 | ||
| Pubmed | Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist. | 2.75e-05 | 4 | 75 | 2 | 22538808 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 2521882 | ||
| Pubmed | 3.04e-05 | 28 | 75 | 3 | 32868762 | ||
| Pubmed | 4.12e-05 | 591 | 75 | 8 | 15231748 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 8525373 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 24244314 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 8855272 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 17330138 | ||
| Pubmed | Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. | 4.57e-05 | 5 | 75 | 2 | 15630139 | |
| Pubmed | Ly6e expression is restricted to syncytiotrophoblast cells of the mouse placenta. | 4.57e-05 | 5 | 75 | 2 | 23830620 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 16467978 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 9521068 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 10540332 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 20691261 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 9187081 | ||
| Pubmed | Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. | 4.57e-05 | 5 | 75 | 2 | 9311871 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 25725491 | ||
| Pubmed | Genome-wide association scan of dental caries in the permanent dentition. | 5.02e-05 | 33 | 75 | 3 | 23259602 | |
| Pubmed | Expression of Dlx genes during the development of the murine dentition. | 6.84e-05 | 6 | 75 | 2 | 11180832 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 24486487 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 12050188 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 11069141 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 24339898 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 23878190 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 11973278 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 23431040 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 12377948 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 23648818 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 1972563 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 17164413 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 38873887 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 12960284 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 12401480 | ||
| Pubmed | MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. | 9.57e-05 | 7 | 75 | 2 | 12393512 | |
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 28092793 | ||
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 11358480 | ||
| Pubmed | Roles for Msx and Dlx homeoproteins in vertebrate development. | 1.27e-04 | 8 | 75 | 2 | 10773441 | |
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 11069716 | ||
| Pubmed | Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. | 1.27e-04 | 8 | 75 | 2 | 23112334 | |
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 24370436 | ||
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 9510207 | ||
| Pubmed | Expression of mouse Foxi class genes in early craniofacial development. | 1.27e-04 | 8 | 75 | 2 | 15376323 | |
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 19185569 | ||
| Pubmed | Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. | 1.27e-04 | 8 | 75 | 2 | 27879269 | |
| Pubmed | A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. | 1.27e-04 | 8 | 75 | 2 | 15498767 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.46e-04 | 908 | 75 | 9 | 19274049 | |
| Pubmed | Transcriptional analysis of Gli3 mutants identifies Wnt target genes in the developing hippocampus. | 1.46e-04 | 47 | 75 | 3 | 22235033 | |
| Pubmed | A mechanism for the suppression of homologous recombination in G1 cells. | 1.64e-04 | 9 | 75 | 2 | 26649820 | |
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 33046212 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 2521353 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 17525185 | ||
| Pubmed | Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. | 1.64e-04 | 9 | 75 | 2 | 14761932 | |
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 25449536 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 7789623 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 20046229 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 12393595 | ||
| Pubmed | Hmx2 homeobox gene control of murine vestibular morphogenesis. | 1.64e-04 | 9 | 75 | 2 | 11748138 | |
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 15381731 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 8496601 | ||
| Pubmed | CC family chemokines directly regulate myoblast responses to skeletal muscle injury. | 2.04e-04 | 10 | 75 | 2 | 18566004 | |
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 30471926 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 11756344 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 18448564 | ||
| Pubmed | An endothelin-1 switch specifies maxillomandibular identity. | 2.04e-04 | 10 | 75 | 2 | 19017795 | |
| Interaction | SP7 interactions | 1.27e-05 | 304 | 72 | 8 | int:SP7 | |
| Interaction | DYRK1B interactions | 1.85e-05 | 91 | 72 | 5 | int:DYRK1B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q14 | 5.19e-05 | 244 | 75 | 5 | chr13q14 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | ZCCHC14 USP5 PIEZO2 ADAMTS9 FNDC3A ZFHX3 DLX5 SFI1 HIF3A KDM5D DCK MAP3K21 | 1.26e-05 | 801 | 71 | 12 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-08 | 181 | 75 | 7 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-08 | 181 | 75 | 7 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 4.79e-07 | 173 | 75 | 6 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.66e-07 | 178 | 75 | 6 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.79e-07 | 188 | 75 | 6 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-06 | 198 | 75 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-06 | 200 | 75 | 6 | 046a3a4d7e4d84ee4252a695ffd4a6aee8b77070 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-06 | 200 | 75 | 6 | 893cc7f6b9794da90aa0c9d721b8647dc97201cd | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-06 | 200 | 75 | 6 | 3d677f13e429abc805a52ec2b8f36c703f511569 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-06 | 200 | 75 | 6 | 12518f4a8d01fc66b72878cdf0ba124b37cff3d8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.02e-06 | 166 | 75 | 5 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 9.02e-06 | 166 | 75 | 5 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.56e-06 | 168 | 75 | 5 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.56e-06 | 168 | 75 | 5 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 170 | 75 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 172 | 75 | 5 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 172 | 75 | 5 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 184 | 75 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 185 | 75 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 185 | 75 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.52e-05 | 185 | 75 | 5 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 187 | 75 | 5 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 188 | 75 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-05 | 188 | 75 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-05 | 189 | 75 | 5 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.69e-05 | 189 | 75 | 5 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 1.73e-05 | 190 | 75 | 5 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.87e-05 | 193 | 75 | 5 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 196 | 75 | 5 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 196 | 75 | 5 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-05 | 197 | 75 | 5 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-05 | 197 | 75 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-05 | 197 | 75 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-05 | 197 | 75 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-05 | 198 | 75 | 5 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-05 | 198 | 75 | 5 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-05 | 198 | 75 | 5 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 199 | 75 | 5 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 199 | 75 | 5 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 199 | 75 | 5 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 199 | 75 | 5 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.21e-05 | 200 | 75 | 5 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.21e-05 | 200 | 75 | 5 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-05 | 200 | 75 | 5 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-05 | 200 | 75 | 5 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.21e-05 | 200 | 75 | 5 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.21e-05 | 200 | 75 | 5 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 150 | 75 | 4 | 6785b695a01de47a47f5c94fdc432428ef80bada | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 150 | 75 | 4 | ddfb7dd696f06e834c45d6c3f9b1138bc17d62b3 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.36e-04 | 155 | 75 | 4 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.43e-04 | 157 | 75 | 4 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 160 | 75 | 4 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 160 | 75 | 4 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.58e-04 | 161 | 75 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 164 | 75 | 4 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 164 | 75 | 4 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 164 | 75 | 4 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | Severe-CD8+_T|World / Disease group and Cell class | 1.72e-04 | 64 | 75 | 3 | 3e7ede6ec5d8b9c4fc6f3aa8fda91fd9b763ef18 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 165 | 75 | 4 | e381bcd558745f3a60346f78b49d0b2672184baa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 165 | 75 | 4 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 167 | 75 | 4 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 167 | 75 | 4 | 99db8871c62336bd215efb65e969783d2b6003b0 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 167 | 75 | 4 | aef22535a76e93472bcedacbb2c6991f3c9c8cd5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 168 | 75 | 4 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.85e-04 | 168 | 75 | 4 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 168 | 75 | 4 | b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6 | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-04 | 168 | 75 | 4 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 169 | 75 | 4 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 169 | 75 | 4 | 0c341f91dc21aaf92bead18d59684d11510502ce | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 169 | 75 | 4 | ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 169 | 75 | 4 | 49a54fb2ea9db5c45e107f304838c536908308bb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-04 | 170 | 75 | 4 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-04 | 170 | 75 | 4 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-mature_conventional_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 171 | 75 | 4 | d934d68efc5739483c735dc702ccd30b07a6aa7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 171 | 75 | 4 | c60313b045cb77c0923ddb81bbd1a654aa1087c5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 171 | 75 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.98e-04 | 171 | 75 | 4 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 172 | 75 | 4 | adc09c4d1b63fe84150516beb692db1e7f7ac980 | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 2.03e-04 | 172 | 75 | 4 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 172 | 75 | 4 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 172 | 75 | 4 | 001d2553a0b5dae3269727bda8ef8067deebab0d | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 2.12e-04 | 174 | 75 | 4 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-04 | 174 | 75 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-04 | 174 | 75 | 4 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 175 | 75 | 4 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.17e-04 | 175 | 75 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.17e-04 | 175 | 75 | 4 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 176 | 75 | 4 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.26e-04 | 177 | 75 | 4 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 177 | 75 | 4 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 177 | 75 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 177 | 75 | 4 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 177 | 75 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 178 | 75 | 4 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 2.31e-04 | 178 | 75 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.31e-04 | 178 | 75 | 4 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.36e-04 | 179 | 75 | 4 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.36e-04 | 179 | 75 | 4 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| Disease | Pancreatic carcinoma, familial | 2.09e-04 | 9 | 72 | 2 | C2931038 | |
| Disease | Connective Tissue Diseases | 4.50e-04 | 13 | 72 | 2 | C0009782 | |
| Disease | 3-hydroxyphenylacetic acid measurement | 5.24e-04 | 14 | 72 | 2 | EFO_0010448 | |
| Disease | response to mepolizumab, Glucocorticoid use measurement | 8.76e-04 | 18 | 72 | 2 | EFO_0008459, EFO_0009942 | |
| Disease | haptoglobin measurement | 1.20e-03 | 21 | 72 | 2 | EFO_0004640 | |
| Disease | gas trapping measurement | 2.28e-03 | 29 | 72 | 2 | EFO_0007628 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASAPLSMDDPSPCGT | 556 | Q12774 | |
| SNMTNFLCPSSPTTP | 926 | Q12774 | |
| PSMSLASPQPCGLAS | 271 | Q9C073 | |
| MPFPNCSAPSTVVAT | 1 | O00270 | |
| DPFILSLPPSSCMSG | 1316 | Q9UKA4 | |
| NSDSMACNSPPSPAL | 201 | O60479 | |
| SPSSSDPMACNSPQS | 206 | P56178 | |
| SSDDFCRMPPPCSDS | 461 | Q9NTI2 | |
| MSSCLQSPPSQSPDS | 111 | Q09MP3 | |
| PRELPSASTSCPSDM | 981 | Q5T481 | |
| TPVMGSPSCDPFNTS | 381 | Q86W92 | |
| MAPPTTPCSTDVCDS | 1536 | O75197 | |
| PLAPSLMASSPTSIC | 1161 | Q9BY66 | |
| ADNDAASMPCTRPPS | 316 | P54764 | |
| AFCSPALSAPMGSDP | 16 | P13236 | |
| ALSAPMGSDPPTACC | 21 | P13236 | |
| MPPPQAFTCNTADAP | 551 | Q8IXI2 | |
| PSPHPPAQMSTFCKS | 976 | O95206 | |
| MPCSPSASSLCAASP | 6 | G5E9R7 | |
| SPNYPTTMSCSESPA | 11 | P31260 | |
| QYASNASSPMPCSPS | 721 | Q13219 | |
| ASLDFDPMSFQCSPP | 791 | A7KAX9 | |
| CSRLAPPPMSQSTCS | 831 | P28290 | |
| SASFPHTTPSMCLNP | 206 | Q15366 | |
| AACTPPASPEPMSAL | 701 | Q8WX93 | |
| TDMCSPAFPILGTTP | 721 | Q86YC2 | |
| SPTPPLCSNMEFPCS | 1941 | Q5VYJ5 | |
| SMSPCPQRTPDSGLA | 1291 | Q9P2N4 | |
| APLPTSCNPSDMSHG | 226 | P34913 | |
| ALSAPMGSDPPTACC | 21 | Q8NHW4 | |
| LFFMNADTAPTSPCP | 1111 | Q8NF50 | |
| MPSQSACPVLSTAPG | 1 | Q5SR53 | |
| YTSGCAPSMPASPVL | 461 | Q9Y2H6 | |
| SLNAPCGPVPSSSQM | 1211 | Q86UU0 | |
| SSFNPAMSDPNRPPC | 286 | P16870 | |
| PAMARTSSRAPCSPT | 1001 | Q76NI1 | |
| MATPPKRSCPSFSAS | 1 | P27707 | |
| MAQSAPSEAPSCSPF | 231 | Q00013 | |
| LPPCSNSSSFSMPLF | 36 | Q96PD2 | |
| MSSFDLPAPSPPRCS | 1 | Q12951 | |
| PPSGAPCLNSFLSSM | 271 | Q12951 | |
| QDLPPASSSCPSMSR | 206 | Q8IYL3 | |
| FMACSPPPLSASCSP | 331 | Q9NYF3 | |
| QMHSPPSSVACSLPG | 616 | O43304 | |
| CESNSTMPGPSLESP | 176 | Q86X76 | |
| SDFPNPCSSGMPAFE | 301 | Q3ZCN5 | |
| SPPGTPVSSCQMRFD | 181 | P43354 | |
| PLSSFMPCGAAAPAR | 1086 | A8K8P3 | |
| SFTLTAPPPCRCMTS | 16 | Q9UQF0 | |
| APPPCRCMTSSSPYQ | 21 | Q9UQF0 | |
| LPSSMAALPASCAPA | 131 | Q6BEB4 | |
| LCPSSPDSPSSSCSM | 256 | B4DZS4 | |
| PDSPSSSCSMACSLP | 261 | B4DZS4 | |
| LCPSSPDSPSSSCSM | 161 | Q5H9J9 | |
| PDSPSSSCSMACSLP | 166 | Q5H9J9 | |
| SEMLTPDFCPTAPGS | 831 | Q5TCX8 | |
| CSSPSRGDPSASSPM | 551 | Q9Y2N7 | |
| CPPISLPAAASRSSM | 41 | P41250 | |
| PSMCGSAPSVFPSCK | 321 | Q53H47 | |
| SSCPPRALSCPSQTM | 221 | Q8NDZ2 | |
| MDISALSSPSCSPSP | 366 | Q8NDZ2 | |
| MSRPSSTGPSANKPC | 1 | O43255 | |
| QASPASSCLEGPAMP | 226 | Q9NZP6 | |
| SCLLQPPSCPNGMSA | 276 | Q96QB1 | |
| ASMACAPPSAASGPL | 41 | Q86YF9 | |
| SPAFAMSPVPGSACT | 301 | Q8IZF4 | |
| AAGDLTMSPPTCPDT | 251 | Q8WWU5 | |
| PVSMTSPGKPSYCSC | 611 | Q8N2E2 | |
| PSVYHAMPSPCSCMS | 61 | Q96P53 | |
| AMPSPCSCMSFNPET | 66 | Q96P53 | |
| VCLTSFPSSPVCPGM | 366 | Q9NS62 | |
| FPSSPVCPGMSLEAS | 371 | Q9NS62 | |
| MPAANSPCTLPSGEA | 1396 | Q9H5I5 | |
| TPVESSPCSFQTPMN | 681 | Q6P2S7 | |
| APSPTSAAHMPCSLG | 2086 | Q96JG9 | |
| PSPAMASYAASPSHC | 2636 | Q96JG9 | |
| SPMTAAACSPPANFS | 96 | Q8IYN6 | |
| SFANMATLPSCPAPS | 716 | Q8WYQ9 | |
| ASPPSVMTASLCRDP | 416 | Q96F45 | |
| PCPSPAASMPALDSE | 361 | Q53EQ6 | |
| CMLPSEPSSSPRDFS | 2026 | P31629 | |
| PASPACSSPPSSEFM | 946 | P51784 | |
| SFCSPHFSSPTSPML | 641 | P45974 | |
| SCSTPMPSQAYSAPA | 2381 | Q15911 | |
| PSSSPMDSYPGLCQS | 1936 | O14686 |